{"id":"https://openalex.org/W2007475412","doi":"https://doi.org/10.1158/1538-7445.am2011-733","title":"Abstract 733: A therapeutic opportunity in melanoma: Targeting CXCR1/2-dependent signaling attenuates therapy resistance","display_name":"Abstract 733: A therapeutic opportunity in melanoma: Targeting CXCR1/2-dependent signaling attenuates therapy resistance","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W2007475412","doi":"https://doi.org/10.1158/1538-7445.am2011-733","mag":"2007475412"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2011-733","doi":"https://doi.org/10.1158/1538-7445.am2011-733","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-733","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101955070","display_name":"Sheng Wu","orcid":"https://orcid.org/0000-0003-2038-8121","observed_orcids":["https://orcid.org/0000-0003-2038-8121"]},"institutions":[{"id":"https://openalex.org/I1307117695","display_name":"Nebraska Medical Center","ror":"https://ror.org/03azxga02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1307117695"]},{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sheng Wu","raw_affiliation_strings":["1University of Nebraska Medical Center, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Nebraska Medical Center, Omaha, NE","institution_ids":["https://openalex.org/I1307117695","https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051129825","display_name":"Michelle L. Varney","orcid":"https://orcid.org/0000-0001-5339-2077","observed_orcids":["https://orcid.org/0000-0001-5339-2077"]},"institutions":[{"id":"https://openalex.org/I1307117695","display_name":"Nebraska Medical Center","ror":"https://ror.org/03azxga02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1307117695"]},{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle L. Varney","raw_affiliation_strings":["1University of Nebraska Medical Center, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Nebraska Medical Center, Omaha, NE","institution_ids":["https://openalex.org/I1307117695","https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115603189","display_name":"Seema Singh","orcid":"https://orcid.org/0000-0002-7188-3803","observed_orcids":["https://orcid.org/0000-0002-7188-3803"]},"institutions":[{"id":"https://openalex.org/I4210089171","display_name":"USA Mitchell Cancer Institute","ror":"https://ror.org/009wx7055","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210089171"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Seema Singh","raw_affiliation_strings":["2USA Mitchell Cancer Institute, Mobile, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2USA Mitchell Cancer Institute, Mobile, AL","institution_ids":["https://openalex.org/I4210089171"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033322099","display_name":"Rakesh K. Singh","orcid":"https://orcid.org/0000-0002-1317-3520","observed_orcids":["https://orcid.org/0000-0002-1317-3520"]},"institutions":[{"id":"https://openalex.org/I1307117695","display_name":"Nebraska Medical Center","ror":"https://ror.org/03azxga02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1307117695"]},{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rakesh K. Singh","raw_affiliation_strings":["1University of Nebraska Medical Center, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of Nebraska Medical Center, Omaha, NE","institution_ids":["https://openalex.org/I1307117695","https://openalex.org/I59130452"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"71","issue":"8_Supplement","first_page":"733","last_page":"733"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8709999918937683},{"id":"https://openalex.org/keywords/cxcr1","display_name":"CXCR1","score":0.824999988079071},{"id":"https://openalex.org/keywords/cxcr2","display_name":"CXCR2","score":1.0},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.9879999756813049},{"id":"https://openalex.org/keywords/cxcl1","display_name":"CXCL1","score":0.8840000033378601},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.8090000152587891},{"id":"https://openalex.org/keywords/dacarbazine","display_name":"dacarbazine","score":0.9829999804496765},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":1.0},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.8669999837875366},{"id":"https://openalex.org/keywords/a375-cells","display_name":"A375 cells","score":0.7429999709129333},{"id":"https://openalex.org/keywords/chemokine-signaling","display_name":"chemokine signaling","score":0.8410000205039978},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6809999942779541},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.8519999980926514},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.7739999890327454},{"id":"https://openalex.org/keywords/tumor-invasion","display_name":"tumor invasion","score":0.7200000286102295}],"concepts":[{"id":"https://openalex.org/C2780964509","wikidata":"https://www.wikidata.org/wiki/Q416975","display_name":"Dacarbazine","level":3,"score":0.8429802060127258},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.8058750033378601},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.6668712496757507},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.649635910987854},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.5105503797531128},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4694226384162903},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.45437902212142944},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4290744662284851},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37645724415779114},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34802016615867615},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3356325626373291},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17961904406547546},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2011-733","doi":"https://doi.org/10.1158/1538-7445.am2011-733","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-733","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2780032723","https://openalex.org/W7096415087","https://openalex.org/W2967960092","https://openalex.org/W2161286605","https://openalex.org/W1990893819","https://openalex.org/W1521472215","https://openalex.org/W2123116698","https://openalex.org/W2062275568","https://openalex.org/W2071653678","https://openalex.org/W2246847349"],"abstract_inverted_index":{"Abstract":[0],"Advanced":[1],"melanoma":[2,29,74,104,232,245],"is":[3,20,38,51],"one":[4],"of":[5,25,35,42,120,128,152,179,203,212,219,253,283,288],"the":[6,23,126,160,216,258,284,289],"most":[7,36],"intractable":[8],"tumors,":[9],"due":[10],"to":[11,14,40,184,267],"its":[12],"insensitivity":[13],"all":[15],"current":[16],"treatment.":[17,181],"Systemic":[18],"chemotherapy":[19,90,249,271],"still":[21],"considered":[22],"mainstay":[24],"treatment":[26,151],"for":[27,65,98,236,292],"advanced":[28,273],"with":[30,270],"limited":[31],"survival":[32],"impact.":[33],"Failure":[34],"agents":[37],"attributed":[39],"development":[41],"therapy":[43],"resistance.":[44],"Our":[45,207],"previous":[46],"findings":[47],"demonstrate":[48,243],"that":[49,84,210,244,247],"CXCL-8":[50,121],"a":[52,228,263],"critical":[53],"mediator":[54],"in":[55,131,159,167,221,231,272],"tumor":[56],"growth,":[57],"invasion,":[58],"and":[59,68,75,92,110,117,134,137,146,154,162,169,177,205,256],"angiogenesis.":[60],"Two":[61],"high":[62,118],"affinity":[63],"receptors":[64],"CXCL-8,":[66],"CXCR1":[67,204,213],"CXCR2,":[69],"are":[70],"differentially":[71],"expressed":[72],"on":[73,79,175],"endothelial":[76],"cells.":[77],"Based":[78],"these":[80],"observations,":[81],"we":[82,124,196,224],"hypothesize":[83],"targeting":[85,257],"CXCR1/2-dependent":[86,259],"signaling":[87],"will":[88,93],"attenuate":[89],"resistance":[91],"synergistically":[94],"enhance":[95],"chemotherapeutic":[96,180,194],"response":[97,230],"malignant":[99],"melanoma.":[100,274],"We":[101],"used":[102,197],"human":[103],"cell":[105],"lines":[106],"A375P":[107,168],"(low":[108],"metastatic)":[109],"A375SM":[111,170,198],"(highly":[112],"metastatic),":[113],"which":[114,172],"express":[115,250],"low":[116],"levels":[119,164,202,252],"respectively.":[122],"First,":[123],"evaluated":[125],"role":[127],"CXCR1/2":[129,188,254],"ligands":[130,255],"chemo-resistance.":[132],"CXCL-1":[133,161],"-8":[135,163],"mRNA":[136],"protein":[138],"expression":[139,189],"was":[140,165,173],"analyzed":[141],"by":[142],"quantitative":[143],"realtime":[144],"PCR":[145],"enzyme-linked":[147],"immunosorbant":[148],"assay,":[149],"following":[150],"dacarbazine":[153,220],"temozolomide.":[155],"A":[156],"significant":[157],"increase":[158],"observed":[166],"cells":[171,199,233,246],"dependent":[174],"concentration":[176],"duration":[178],"In":[182],"order":[183],"test":[185],"whether":[186],"blocking":[187],"using":[190],"genetic":[191],"knock-down":[192],"modulates":[193],"responses,":[195],"expressing":[200],"different":[201],"CXCR2.":[206,237],"data":[208,242],"suggest":[209],"knockdown":[211],"significantly":[214],"enhanced":[215],"cytotoxic":[217],"effect":[218],"vitro.":[222],"However,":[223],"did":[225],"not":[226],"observe":[227],"similar":[229],"knocked":[234],"down":[235],"Taken":[238],"together,":[239],"our":[240],"preliminary":[241],"survive":[248],"higher":[251],"pathway":[260],"might":[261],"be":[262,268],"potential":[264],"therapeutic":[265],"approach":[266],"combined":[269],"Citation":[275],"Format:":[276],"{Authors}.":[277],"{Abstract":[278],"title}":[279],"[abstract].":[280],"In:":[281],"Proceedings":[282],"102nd":[285],"Annual":[286],"Meeting":[287],"American":[290],"Association":[291],"Cancer":[293,303],"Research;":[294],"2011":[295],"Apr":[296],"2-6;":[297],"Orlando,":[298],"FL.":[299],"Philadelphia":[300],"(PA):":[301],"AACR;":[302],"Res":[304],"2011;71(8":[305],"Suppl):Abstract":[306],"nr":[307],"733.":[308],"doi:10.1158/1538-7445.AM2011-733":[309]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}